145 related articles for article (PubMed ID: 8611689)
1. Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid.
Estey E; Thall PF; Mehta K; Rosenblum M; Brewer T; Simmons V; Cabanillas F; Kurzrock R; Lopez-Berestein G
Blood; 1996 May; 87(9):3650-4. PubMed ID: 8611689
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.
Adamson PC; Reaman G; Finklestein JZ; Feusner J; Berg SL; Blaney SM; O'Brien M; Murphy RF; Balis FM
J Clin Oncol; 1997 Nov; 15(11):3330-7. PubMed ID: 9363862
[TBL] [Abstract][Full Text] [Related]
3. Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid.
Douer D; Estey E; Santillana S; Bennett JM; Lopez-Bernstein G; Boehm K; Williams T
Blood; 2001 Jan; 97(1):73-80. PubMed ID: 11133744
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.
Ozpolat B; Lopez-Berestein G; Adamson P; Fu CJ; Williams AH
J Pharm Pharm Sci; 2003; 6(2):292-301. PubMed ID: 12935441
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
Thomas X; Dombret H; Cordonnier C; Pigneux A; Gardin C; Guerci A; Vekhoff A; Sadoun A; Stamatoullas A; Fegueux N; Maloisel F; Cahn JY; Reman O; Gratecos N; Berthou C; Huguet F; Kotoucek P; Travade P; Buzyn A; de Revel T; Vilque JP; Naccache P; Chomienne C; Degos L; Fenaux P
Leukemia; 2000 Jun; 14(6):1006-13. PubMed ID: 10865965
[TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
[TBL] [Abstract][Full Text] [Related]
7. Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia.
Estey EH; Giles FJ; Kantarjian H; O'Brien S; Cortes J; Freireich EJ; Lopez-Berestein G; Keating M
Blood; 1999 Oct; 94(7):2230-5. PubMed ID: 10498593
[TBL] [Abstract][Full Text] [Related]
8. Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid.
Estey E; Koller C; Cortes J; Reed P; Freireich E; Giles F; Kantarjian H
Leuk Lymphoma; 2001 Jul; 42(3):309-16. PubMed ID: 11699395
[TBL] [Abstract][Full Text] [Related]
9. Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.
Tsimberidou AM; Tirado-Gomez M; Andreeff M; O'Brien S; Kantarjian H; Keating M; Lopez-Berestein G; Estey E
Leuk Lymphoma; 2006 Jun; 47(6):1062-8. PubMed ID: 16840198
[TBL] [Abstract][Full Text] [Related]
10. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.
Avvisati G; Lo Coco F; Diverio D; Falda M; Ferrara F; Lazzarino M; Russo D; Petti MC; Mandelli F
Blood; 1996 Aug; 88(4):1390-8. PubMed ID: 8695858
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia.
Castaigne S; Lefebvre P; Chomienne C; Suc E; Rigal-Huguet F; Gardin C; Delmer A; Archimbaud E; Tilly H; Janvier M
Blood; 1993 Dec; 82(12):3560-3. PubMed ID: 8260694
[TBL] [Abstract][Full Text] [Related]
12. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.
Adamson PC; Bailey J; Pluda J; Poplack DG; Bauza S; Murphy RF; Yarchoan R; Balis FM
J Clin Oncol; 1995 May; 13(5):1238-41. PubMed ID: 7738627
[TBL] [Abstract][Full Text] [Related]
14. All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial.
Belhabri A; Thomas X; Wattel E; Chelghoum Y; Anglaret B; Vekhoff A; Reman O; Dombret H; Dhedin N; Michallet M; Fière D; Archimbaud E
Hematol J; 2002; 3(1):49-55. PubMed ID: 11960396
[TBL] [Abstract][Full Text] [Related]
15. All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia.
Cortes JE; Kantarjian H; O'Brien S; Robertson LE; Koller C; Hirsh-Ginsberg C; Stass S; Keating M; Estey E
Cancer; 1994 Jun; 73(12):2946-52. PubMed ID: 8199992
[TBL] [Abstract][Full Text] [Related]
16. Management of acute promyelocytic leukemia relapse in the ATRA era.
Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
[TBL] [Abstract][Full Text] [Related]
17. Liposomal-all-trans-retinoic acid in treatment of acute promyelocytic leukemia.
Ozpolat B; Lopez-Berestein G
Leuk Lymphoma; 2002 May; 43(5):933-41. PubMed ID: 12148903
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
Chen G; Shen Z; Zhu AP
Zhonghua Nei Ke Za Zhi; 1997 May; 36(5):295-9. PubMed ID: 10374268
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
Hirota T; Fujimoto T; Konno K; Sakakibara Y; Katano N; Tsurusawa M; Takitani K; Miyake M
Rinsho Ketsueki; 1997 Nov; 38(11):1170-6. PubMed ID: 9423333
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics.
Conley BA; Egorin MJ; Sridhara R; Finley R; Hemady R; Wu S; Tait NS; Van Echo DA
Cancer Chemother Pharmacol; 1997; 39(4):291-9. PubMed ID: 9025769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
